NCT02022644View on ClinicalTrials.gov

Study of Convection-Enhanced, Image-Assisted Delivery of Liposomal-Irinotecan In Recurrent High Grade Glioma

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

October 23, 2014

Primary Completion Date

December 31, 2020

Study Completion Date

May 31, 2023

Conditions
High Grade Glioma
Interventions
DRUG

nanoliposomal irinotecan

The drug named here (nanoliposomal irinotecan) will be used in varying amounts, based on tumor volume.

Trial Locations (1)

94143

University of California, San Francisco, San Francisco

Sponsors

Collaborators (1)

Ipsen
All Listed Sponsors
collaborator

Ipsen

INDUSTRY

collaborator

National Cancer Institute (NCI)

NIH

lead

University of California, San Francisco

OTHER